Summary
Thermo Fisher Scientific Inc. (TMO) filed an Amendment No. 1 to its Form 8-K on August 8, 2011, to supplement a previous filing from July 12, 2011. The primary purpose of this amendment is to add Exhibit 23.2, which pertains to consent from a third party, likely related to previously disclosed information. Investors should note that this filing does not introduce new financial results or material business updates beyond the addition of this exhibit.
Key Highlights
- 1Amendment to a previously filed 8-K report.
- 2Original filing date was July 12, 2011.
- 3The amendment specifically adds Exhibit 23.2.
- 4Exhibit 23.2 is understood to be a third-party consent.
- 5No new financial statements or significant business events are being disclosed in this amendment.
- 6Information from the original 8-K filing remains incorporated by reference.
Frequently Asked Questions
The primary purpose of this Amendment No. 1 to the Form 8-K is to add Exhibit 23.2, which is a third-party consent, to the company's original filing from July 12, 2011.
No, this filing is an amendment solely for the purpose of adding an exhibit. It does not introduce new financial statements or disclose any new material business events.
Exhibit 23.2 commonly represents the consent of an independent third party, such as an auditor, to the incorporation by reference of their report or opinion in a registration statement or other SEC filing.
Based on the information provided, this filing appears to be a procedural administrative update to ensure all necessary documentation is present. It does not signal any new negative developments or significant changes in the company's business or financial standing.